{"id":272728,"date":"2010-02-03T17:01:33","date_gmt":"2010-02-03T22:01:33","guid":{"rendered":"http:\/\/blogs.wsj.com\/health\/2010\/02\/03\/bristol-meyers-squibb-to-freeze-salaries-in-2010\/"},"modified":"2010-02-03T17:01:33","modified_gmt":"2010-02-03T22:01:33","slug":"bristol-myers-squibb-to-freeze-salaries-in-2010","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/272728","title":{"rendered":"Bristol-Myers Squibb to Freeze Salaries in 2010"},"content":{"rendered":"

\"PillThings are tough all over: Bristol-Myers Squibb is freezing employee salaries for the year.<\/p>\n

A Health Blog tipster told us the word went out today. Health Blog colleague Jonathan Rockoff checked in with the company, and a spokeswoman confirmed:<\/p>\n

\n

the elimination of annual salary increases in 2010 for Bristol-Myers Squibb employees worldwide, except where these practices cannot be eliminated based on legal mandate or contractual obligation.<\/p>\n<\/blockquote>\n

The freeze won’t affect bonuses, the company said.<\/p>\n

Bristol said<\/a> earlier this week that its sales rose by 6% in 2009. But the company’s biggest selling drug, Plavix, will face generic competition in the U.S. in 2012. The company has been shedding nonpharmaceutical assets, and has built up a $10 billion<\/a> war chest it can use for acquisitions and licensing.<\/p>\n

Photo: iStockphoto<\/em><\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Things are tough all over: Bristol-Myers Squibb is freezing employee salaries for the year. A Health Blog tipster told us the word went out today. Health Blog colleague Jonathan Rockoff checked in with the company, and a spokeswoman confirmed: the elimination of annual salary increases in 2010 for Bristol-Myers Squibb employees worldwide, except where these […]<\/p>\n","protected":false},"author":650,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-272728","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/272728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/650"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=272728"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/272728\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=272728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=272728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=272728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}